Want to join the conversation?
$ALXN 2Q15 Call: Commercial organization delivered steady growth in both PNH and aHUS, reflecting the strength of core Soliris business. Advanced Strensiq towards commercialization with first approval in Japan and positive CHMP opinion in Europe. In complement franchise, exceeded target enrollment in registration trial of eculizumab.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!